ReviewJAC-antimicrobial resistance2026
Governance of antimicrobial resistance in Central Africa (2015-2025): a systematic review of policies, One Health coordination and funding.
Review in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobial resistance (AMR) poses a major threat to effective treatment and global health security, with disproportionate impacts in low- and middle-income settings. In Central Africa, health system fragility, limited surveillance capacity and weak multisectoral coordination heighten vulnerability. Despite momentum following the WHO Global Action Plan, the status of AMR governance, One Health coordination and financing in the subregion remains insufficiently characterized. Objectives: To systematically assess AMR governance in Central Africa (2015-2025), focusing on policy frameworks, One Health coordination and financing mechanisms. Methods: We conducted a PRISMA 2020-compliant systematic review registered in PROSPERO (CRD420251082393). Six databases were searched, along with grey literature, including national policy documents, institutional reports and consultations with AMR focal points. Eligible sources addressed AMR policy, coordination, surveillance and funding. Results: Of the 4464 records identified, 27 documents were included (19 peer-reviewed articles, one report, seven national action plans). Evidence was concentrated in Cameroon, with limited data from other countries. National action plans aligned with global standards were identified in six countries, while none were available for Equatorial Guinea or the Republic of Congo. Across the region, governance was characterized by partial policy alignment but weak implementation, limited operationalization of One Health, fragmented surveillance and reliance on external funding. Key constraints included inadequate laboratory capacity, weak stewardship systems and insufficient domestic financing. Conclusion: AMR governance in Central Africa has progressed at the policy level but remains operationally constrained. Bridging the gap between policy and implementation requires strengthened institutionalization of One Health, improved accountability and sustainable domestic investment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.